Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Top Cited Papers
- 20 March 2020
- journal article
- research article
- Published by Elsevier BV in International Journal of Antimicrobial Agents
- Vol. 56 (1), 105949
- https://doi.org/10.1016/j.ijantimicag.2020.105949
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Whipple's disease and Tropheryma whipplei infections: when to suspect them and how to diagnose and treat themCurrent Opinion in Infectious Diseases, 2018
- Azithromycin Inhibits the Replication of Zika VirusJournal of Antivirals & Antiretrovirals, 2018
- Simultaneous UHPLC-UV analysis of hydroxychloroquine, minocycline and doxycycline from serum samples for the therapeutic drug monitoring of Q fever and Whipple’s diseaseJournal of Chromatography B, 2017
- Zika virus cell tropism in the developing human brain and inhibition by azithromycinProceedings of the National Academy of Sciences of the United States of America, 2016
- Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)Ophthalmology, 2016
- Early Administration of Azithromycin and Prevention of Severe Lower Respiratory Tract Illnesses in Preschool Children With a History of Such IllnessesJAMA, 2015
- Evaluation of Ebola Virus Inhibitors for Drug RepurposingACS Infectious Diseases, 2015
- Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal modelProceedings of the National Academy of Sciences of the United States of America, 2008
- Design and Synthesis of Hydroxyferroquine Derivatives with Antimalarial and Antiviral ActivitiesJournal of Medicinal Chemistry, 2006
- Treatment of Q Fever EndocarditisArchives of Internal Medicine, 1999